Johannes Ring Selected Research

potassium metabisulfite

1/2013

Clonal mast cell activation syndrome with anaphylaxis to sulfites.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johannes Ring Research Topics

Disease

50	Hypersensitivity (Allergy) 01/2022 - 01/2002
47	Atopic Dermatitis (Atopic Eczema) 01/2020 - 01/2002
32	Anaphylaxis (Anaphylactic Shock) 01/2022 - 01/2002
16	Asthma (Bronchial Asthma) 01/2021 - 01/2006
12	Inflammation (Inflammations) 01/2021 - 06/2002
12	Eczema 10/2016 - 01/2002
8	Skin Diseases (Skin Disease) 01/2021 - 11/2002
8	Infections 01/2020 - 01/2004
7	COVID-19 08/2021 - 01/2020
7	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2016 - 11/2002
6	Seasonal Allergic Rhinitis (Hay Fever) 01/2018 - 04/2003
5	Allergic Rhinitis 01/2021 - 01/2003
5	Urticaria (Hives) 01/2020 - 02/2002
5	Neoplasms (Cancer) 11/2013 - 02/2005
4	Contact Dermatitis (Eczema, Contact) 07/2014 - 01/2008
4	Pruritus (Itching) 03/2013 - 02/2006
4	Hypereosinophilic Syndrome (Loeffler Endocarditis) 02/2013 - 03/2008
3	Allergic Contact Dermatitis 01/2021 - 04/2007
3	Chronic Urticaria 01/2021 - 01/2013
3	Pain (Aches) 10/2018 - 03/2003
3	Angioedema 04/2012 - 02/2002
3	Fabry Disease (Fabry's Disease) 02/2010 - 01/2003
2	Pemphigus (Pemphigus Vulgaris) 01/2021 - 07/2012
2	Bullous Pemphigoid (Pemphigoid) 01/2021 - 07/2012
2	Peanut Hypersensitivity (Peanut Allergy) 01/2021 - 03/2008
2	Disease Progression 01/2020 - 03/2013
2	Shock 01/2018 - 01/2010
2	Bites and Stings (Sting) 05/2015 - 01/2014
2	Venom Hypersensitivity 05/2015 - 04/2006
2	Superinfection 03/2013 - 01/2002
2	Alopecia (Baldness) 03/2010 - 01/2005
2	Candidiasis (Moniliasis) 11/2008 - 12/2007
2	Ichthyosis Vulgaris (Dominant Ichthyosis Vulgaris) 06/2008 - 07/2006
2	Drug Hypersensitivity (Drug Allergy) 01/2004 - 01/2002
2	Melanoma (Melanoma, Malignant) 08/2003 - 04/2002
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Nasal Polyps (Nasal Polyp) 01/2020
1	Rhinosinusitis 01/2020

Drug/Important Bio-Agent (IBA)

36	AllergensIBA 01/2022 - 04/2002
35	Immunoglobulin E (IgE)IBA 01/2022 - 01/2002
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2004
7	AntibodiesIBA 01/2022 - 04/2003
7	Epinephrine (Adrenaline)FDA LinkGeneric 01/2021 - 01/2010
7	VaccinesIBA 01/2021 - 06/2011
7	CytokinesIBA 07/2014 - 06/2002
6	AntigensIBA 01/2021 - 01/2007
6	Tryptases (Tryptase)IBA 08/2014 - 01/2003
6	NickelIBA 01/2014 - 06/2004
6	Filaggrin ProteinsIBA 01/2012 - 07/2006
6	Arthropod VenomsIBA 05/2010 - 01/2004
5	pimecrolimus (Elidel)FDA Link 06/2015 - 01/2006
4	Biological ProductsIBA 01/2020 - 01/2008
4	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2015 - 03/2008
4	Histamine (Histamine Dihydrochloride)FDA Link 01/2014 - 01/2010
4	Interleukin-17 (Interleukin 17)IBA 11/2012 - 11/2008
4	LipidsIBA 01/2012 - 05/2002
3	AutoantibodiesIBA 01/2020 - 01/2002
3	Pharmaceutical PreparationsIBA 01/2015 - 01/2002
3	Local Anti-Infective Agents (Antiseptics)IBA 09/2013 - 04/2010
3	mepolizumabIBA 02/2013 - 03/2008
3	VenomsIBA 08/2012 - 04/2006
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2010 - 01/2002
2	Budesonide (Pulmicort)FDA LinkGeneric 08/2021 - 01/2021
2	COVID-19 VaccinesIBA 01/2021 - 01/2021
2	4'-N,N-dimethylamino-4-aminoazobenzeneIBA 01/2021 - 01/2014
2	BNT162 VaccineIBA 01/2021 - 01/2021
2	Monoclonal AntibodiesIBA 01/2020 - 03/2008
2	Immunoglobulin G (IgG)IBA 01/2018 - 01/2004
2	EnzymesIBA 10/2017 - 02/2010
2	SilverIBA 10/2017 - 01/2003
2	Omalizumab (Xolair)FDA Link 01/2016 - 05/2008
2	Eosinophil Cationic ProteinIBA 08/2014 - 01/2003
2	SteroidsIBA 08/2014 - 01/2002
2	Interleukin-10 (Interleukin 10)IBA 07/2014 - 12/2007
2	Histamine Antagonists (Antihistamines)IBA 04/2014 - 03/2013
2	Immunoglobulins (Immunoglobulin)IBA 01/2014 - 08/2011
2	Calcineurin InhibitorsIBA 11/2013 - 01/2008
2	Contrast MediaIBA 08/2011 - 01/2010
2	Interleukin-22 (IL-22)IBA 07/2011 - 11/2008
2	anti-IgE antibodiesIBA 05/2011 - 11/2007
2	Peptide Hydrolases (Proteases)FDA Link 01/2008 - 05/2006
2	Ointments (Pastes)IBA 01/2008 - 01/2002
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2008 - 01/2002
2	APTIBA 01/2006 - 07/2004
2	Interleukin-2 (IL2)IBA 08/2003 - 06/2002
2	Interferon alpha-2 (Roferon-A)FDA Link 08/2003 - 04/2002
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2022
1	nickel sulfate FDA Link 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	AutoantigensIBA 01/2021

Therapy/Procedure

40	Therapeutics 01/2021 - 01/2002
11	Immunotherapy 01/2018 - 01/2003
3	Injections 01/2018 - 01/2003
2	Critical Care (Surgical Intensive Care) 01/2021 - 01/2014
2	Radiotherapy 10/2018 - 09/2012
2	Acupuncture Therapy 07/2014 - 04/2011
2	Lasers (Laser) 08/2009 - 01/2003
2	Enzyme Replacement Therapy 07/2007 - 01/2003
1	Emergency Treatment 01/2021